Efficacy of AI-Based Rehabilitation for Anxiety Disorders NCT07545070
Summary
A clinical trial registration for NCT07545070 on ClinicalTrials.gov describes a study evaluating AI-based rehabilitation combined with standard treatment against treatment as usual alone in patients with anxiety disorders. The trial is registered with an anticipated start date of April 22, 2026, with N/A as the study kind. The trial will assess whether the AI-based intervention improves outcomes compared to standard care alone.
“The trail aimed to test the efficacy of AI-based rehabilitation treatment in patients with anxiety disorders.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This document is a clinical trial registry entry on ClinicalTrials.gov for NCT07545070, a study titled 'The Efficacy of an AI-Based Rehabilitation Treatment in Patients With Anxiety Disorders.' The trial will evaluate whether AI-based rehabilitation combined with treatment as usual is more effective than treatment as usual alone for improving outcomes in patients with anxiety disorders. The study interventions include AI-based rehabilitation treatment combined with standard treatment and treatment as usual (TAU) as comparator.
Affected parties include clinical investigators, mental health researchers, and healthcare providers interested in digital health interventions for anxiety disorders. The trial registration provides public access to study design and recruitment information but creates no compliance obligations.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
The Efficacy of an AI-Based Rehabilitation Treatment in Patients With Anxiety Disorders
N/A NCT07545070 Kind: NA Apr 22, 2026
Abstract
The trail aimed to test the efficacy of AI-based rehabilitation treatment in patients with anxiety disorders. Specifically, the objective of this trial is to determine whether the AI-based rehabilitation combined with treatment as usual is more effective than treatment as usual alone in improving outcomes in patients with anxiety disorders.
Conditions: Anxiety Disorders
Interventions: AI-based rehabilitation treatment combined with standard treatment, Treatment as Usual (TAU)
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.